Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devin B Lowe

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Vaccines|July 27, 2024
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1Jennifer L Taylor, Kathleen M Kokolus, Per H Basse, et al.
Journal of Immunological Methods|March 6, 2007
A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17Maurizio Chiriva-Internati, Fabio Grizzi, Jon A Weidanz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2010
Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigensXi Zhao, Anamika Bose, Hideo Komita, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Vaccines|July 27, 2024
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1Jennifer L Taylor, Kathleen M Kokolus, Per H Basse, et al.
Journal of Immunological Methods|March 6, 2007
A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17Maurizio Chiriva-Internati, Fabio Grizzi, Jon A Weidanz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2010
Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigensXi Zhao, Anamika Bose, Hideo Komita, et al.
Pageof 4